Darinaparsin (ZIO-101) enhances the sensitivity of small-cell lung cancer to PARP inhibitors (vol 0, pg 1, 2022)

被引：1
|
作者：
Cao, Guo-zhen [1 ,2 ,3 ]
Ma, Li-ying [1 ,2 ,3 ]
Zhang, Zong-hui [1 ,4 ]
Wang, Xiao-lin [2 ]
Hua, Jing-han [1 ,2 ,3 ]
Zhang, Jia-hui [1 ,2 ,3 ]
Lv, Yang [1 ,2 ,3 ]
Zhang, Shao-bo [1 ,4 ]
Ou, Jian [5 ]
Lin, Wen-chu [1 ,2 ,3 ]
机构：
[1] Chinese Acad Sci, High Magnet Field Lab, Hefei Inst Phys Sci, Hefei 230031, Peoples R China
[2] Univ Sci & Technol China, Hefei 230036, Peoples R China
[3] Chinese Acad Sci, Key Lab High Magnet Field &Beam Phys Biol, Hefei Inst Phys Sci, Hefei 230031, Peoples R China
[4] Anhui Med Univ, Sch Basic Med, Hefei 230032, Peoples R China
[5] Nanjing Med Univ, Suzhou Municipal Hosp, Ctr Reprod & Genet, Affiliated Suzhou Hosp, Suzhou 215002, Peoples R China
来源：
ACTA PHARMACOLOGICA SINICA | 2023年 / 44卷 / 05期
关键词：
D O I：
10.1038/s41401-022-01019-w
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：1105 / 1106
页数：2
相关论文
共 50 条
  • [41] Small-cell lung cancer: what we know, what we need to know and the path forward (vol 17, pg 725, 2017)
    Gazdar, Adi F.
    Bunn, Paul A.
    Minna, John D.
    NATURE REVIEWS CANCER, 2017, 17 (12) : 765 - 765
  • [42] Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer (vol 76, pg 32, 2012)
    Tanaka, Norimitsu
    Toyooka, Shinichi
    Soh, Junichi
    Kubo, Takafumi
    Yamamoto, Hiromasa
    Maki, Yuho
    Muraoka, Takayuki
    Shien, Kazuhiko
    Furukawa, Masashi
    Ueno, Tsuyoshi
    Asano, Hiroaki
    Tsukuda, Kazunori
    Aoe, Keisuke
    Miyoshi, Shinichiro
    LUNG CANCER, 2017, 108 : 254 - 255
  • [43] Targeting ADRB2 enhances sensitivity of non-small cell lung cancer to VEGFR2 tyrosine kinase inhibitors
    Xu, Yingzhuo
    Wang, Jian
    Wang, Xu
    Zhou, Xiaoshu
    Tang, Jing
    Jie, Xiaohua
    Yang, Xijie
    Rao, Xinrui
    Xu, Yunhong
    Xing, Biyuan
    Li, Zhenyu
    Wu, Gang
    CELL DEATH DISCOVERY, 2022, 8 (01)
  • [44] Targeting ADRB2 enhances sensitivity of non-small cell lung cancer to VEGFR2 tyrosine kinase inhibitors
    Yingzhuo Xu
    Jian Wang
    Xu Wang
    Xiaoshu Zhou
    Jing Tang
    Xiaohua Jie
    Xijie Yang
    Xinrui Rao
    Yunhong Xu
    Biyuan Xing
    Zhenyu Li
    Gang Wu
    Cell Death Discovery, 8
  • [45] Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment (vol 11, pg 3837, 2012)
    Oplustilova, Lenka
    Wolanin, Kamila
    Mistrik, Martin
    Korinkova, Gabriela
    Simkova, Dana
    Bouchal, Jan
    Lenobel, Rene
    Bartkova, Jirina
    Lau, Alan
    O'Connor, Mark J.
    Lukas, Jiri
    Bartek, Jiri
    CELL CYCLE, 2013, 12 (12) : 1978 - 1978
  • [46] Prognostic roles of hematological indicators in programmed cell death protein 1/programmed cell death ligand 1 inhibitors for small-cell lung cancer: a retrospective cohort study
    Du, Jiya
    Zhang, Qian
    Tian, Le
    Chen, Yishan
    Tian, Ye
    Dempke, Wolfram C. M.
    Arasanz, Hugo
    Soo, Ross Andrew
    Zhou, Zhiguo
    Meng, Qingju
    Liu, Yibing
    JOURNAL OF THORACIC DISEASE, 2024, 16 (12) : 8669 - 8683
  • [47] Efficacy and safety analysis of anlotinib in combination with immune checkpoint inhibitors for second-line and subsequent extensive-stage small-cell lung cancer (vol 71, pg 297, 2024)
    Ying, Xixi
    Shi, Zheng
    Shao, Rongjun
    You, Guangxian
    Song, Zhengbo
    NEOPLASMA, 2024, 71 (05)
  • [48] Inhibition of CDK9 Enhances Radiation Sensitivity of Non-Small Cell Lung Cancer Cells, Increases PARP Cleavage, and Reduces the Level of Antiapoptotic Proteins
    McCool, J. K.
    Ashamalla, H.
    Graves, L. M.
    Graves, P. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E530 - E530
  • [49] Knockdown of NUPR1 Enhances the Sensitivity of Non-small-cell Lung Cancer Cells to Metformin by AKT Inhibition
    Kim, Yu Jin
    Hong, Sung-Eun
    Jang, Se-Kyeong
    Park, Ki Soo
    Kim, Chun-Ho
    Park, In-Chul
    Jin, Hyeon-Ok
    ANTICANCER RESEARCH, 2022, 42 (07) : 3475 - 3481
  • [50] Reconsidering N component of cancer staging for T1-2N0-2M0 small-cell lung cancer: a retrospective study based on multicenter cohort
    Lei-Lei Wu
    Li-Hong Qiu
    Xiaolu Chen
    Wan-Jun Yu
    Chong-Wu Li
    Jia-Yi Qian
    Shen-Hua Liang
    Peng Lin
    Hao Long
    Lan-Jun Zhang
    Zhi-Xin Li
    Kun Li
    Feng Jiang
    Guo-Wei Ma
    Dong Xie
    Respiratory Research, 24
12345